Navigation Links
Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference
Date:5/29/2008

RICHMOND, Calif., May 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on Sangamo's diabetic neuropathy programs at 1:40 p.m. (ET) on Friday, June 6, 2008, at the Canaccord Adams Diabetes and Obesity Conference in San Francisco.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy. Phase 1 clinical trials are ongoing to evaluate a ZFP Therapeutic for peripheral artery disease. Other therapeutic development programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
2. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
3. Sangamo BioSciences to Present at the 2007 BIO InvestorForum
4. Sangamo BioSciences Announces Third Quarter 2007 Conference Call and Webcast
5. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
6. Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
7. Sangamo BioSciences to Present at the BMO Capital Markets Health Care Conference
8. Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
9. Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast
10. Sangamo BioSciences to Present at the BIO CEO & Investor Conference
11. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, MARKHAM,ON,Nov.25/PRNewswire/-Cytochromatoda...ofDirectors.Dr.MoldtwillreplaceMr.UlrikSporkastheN...fBoardmembersremainsunchangedatsixmembers. ,, "...okforwardtobenefitingfromhisexperienceandguidancea...ngCKD-focusedspecialtypharmaceuticalcompany,"state...
(Date:11/24/2009)...,, HOUSTON,Nov.24/PRNewswire-FirstCall/--IES(Na...ndcommunicationssystemsandservicesforthecommercial...titscommercialbusinessgrouphasbeenawardedacontract...fortheLevel4bio-safetylab(BSL-4)replacementfacilit...Diseases(USAMRIID)atFortDetrickinFrederick,Md. ,...
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-Firs...nouncedthatithasreceivednoticefrom,theNasdaqStockM...spendedasofNovember30,2009andaForm25-NSEwillbefile...removedeCODE,scommonstock,fromlistingonNasdaq,unle...icationsPanel.Thecompanyhasfiledsuchanappeal,which...
(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/...companyfocusedondevelopingandcommercializingnovelp...Tonno,PresidentandChiefExecutiveOfficer,isschedule...ference,tobeheldDecember1-2,2009atTheNewYorkPalace...Ghiglieri,ChiefFinancialOfficer,willbeavailabletor...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...ces,Holdings, Inc. (Nasdaq: ADLS ), today announc...bcast at 10:30 am (EST) on Tuesday, January 22,200...nouncement that was,made yesterday by the US Food ...eting of the Anti-Infective Drugs Advisory Committ...al design for community acquired,pneumonia (CAP).,...
...der in clinical,solutions for radiation therapy an... utilizing Elekta technology to implement clinical...(VMAT)*. With the recent CE designation of,VMAT in...rsden Hospital in,Sutton, UK and General Hospital ...MAT solution., VMAT is a significant improvement ...
... to the,recent comments by certain plaintiff law f...ts, CellCyte Genetics Corporation (the "Company") ...g claims are without merit and,will be shown to be...etained the international law firm of Duane Morris...sly in these matters. Concurrently, the Company,wi...
Other Biology Technology:Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 2Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 3Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability 2Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability 3CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases 2CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases 3
(Date:11/23/2009)....C. The community-associated strain of the deadly...ant to most common antibioticsposes a far greater ...its way into hospitals, according to a study in th.... , The new threat is easily picked up in fitne...as increased the overall burden of MRSA within hos...
(Date:11/23/2009)... by the Wildlife Conservation Society says that we...the Republic of Congopart of the "mother lode" of ... becoming increasingly threatened by growing human... protection of the swamp forests adjacent to the s...recent surveys confirmed that high densities of th...
(Date:11/23/2009)...Ill. A new study provides "incontrovertible evide...he island of Sumatra about 73,000 years ago defore...the epicenter, researchers report. , The volcano...into the atmosphere, leaving a crater (now the wor... long and 35 kilometers wide. Ash from the event h...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine 4938 1Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine 4938 2Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine 4938 3Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine 4938 4Martek Announces Third Quarter 2009 Financial Results 56082 1Martek Announces Third Quarter 2009 Financial Results 56082 2Martek Announces Third Quarter 2009 Financial Results 56082 3Martek Announces Third Quarter 2009 Financial Results 56082 4Martek Announces Third Quarter 2009 Financial Results 56082 5Martek Announces Third Quarter 2009 Financial Results 56082 6Martek Announces Third Quarter 2009 Financial Results 56082 7Martek Announces Third Quarter 2009 Financial Results 56082 8Martek Announces Third Quarter 2009 Financial Results 56082 9Martek Announces Third Quarter 2009 Financial Results 56082 10Martek Announces Third Quarter 2009 Financial Results 56082 11Martek Announces Third Quarter 2009 Financial Results 56082 12Gentiva 28R 29 Health Services Completes Acquisition of Home Health Agency 56080 1Gentiva 28R 29 Health Services Completes Acquisition of Home Health Agency 56080 2Gentiva 28R 29 Health Services Completes Acquisition of Home Health Agency 56080 3
... Research has shown for the first time that human ...rface epithelium (OSE) cells derived from adult hu...SE cells developed in vitro into mature eggs suita...yo. These findings, published today in the Open Ac...y, offer important new strategies for use in in vi...
... Scientists at Washington University School of Med...indow of opportunity" was critical to their earlie...ic pig tissues. , In those experiments, published...they didn,t have to give anti-rejection drugs to d...plants. They had expected rats that received no im...
... Researchers at UCLA and the Veterans Affairs Grea...rgest and most comprehensive study in comparing th...reating hepatitis B -- a disease affecting 350 mil...of Internal Medicine, the study may help physician...hers note that a degree of uncertainly exists on h...
Other Biology News:Human Eggs Can Develop From Ovarian Surface Cells In Vitro 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 3UCLA study assesses cost-effectiveness of Hepatitis B drugs 2UCLA study assesses cost-effectiveness of Hepatitis B drugs 3
... is commonly used as a fusion partner when express...as been reported to enhance the production and in ...When expressed in a soluble, properly folded form,...ilized glutathione. Gentle elution is achieved wit...
...ly of positioners, offering longer travel while ma... patterns mimic the MX80 family, allowing users to...ets to build multi-axis systems., , Miniature lin...ons to 5 gs , Velocities to 3 m/s , Encoder resolu...
...is from the C-terminal end of the mouse retinoic a...nce extends from amino acids 429 to 448 of RAR*. ...nus): C - P - S - V - S - P - S - S - V - E - N - ...inal cysteine has been added to facilitate conjuga...
...ity ready-to-use cryopreserved neural stem cells (...th and lineage commitment. Just thaw and plate the... in the format you need for a tissue-like mixture ...ytes and oligodendrocytes. Better than neurosphere...
Biology Products: